Profil
Evgeny Zaytsev was the founder of Helix Ventures LLC, founded in 2008, where he held the title of General Partner from 2010 to 2011.
He is also the founder of Bering Capital LLC, founded in 2020, where he currently holds the title of Managing Partner.
In his current roles, Dr. Zaytsev is the Director at NovaDigm Therapeutics, Inc. and the Managing Partner at RMI Partners OOO.
Dr. Zaytsev's former positions include Chairman at InteKrin Therapeutics, Inc. from 2011 to 2018, Director at Adastra Pharmaceuticals, Inc., Director at Aldea Pharmaceuticals, Inc., Independent Director at Clearside Biomedical, Inc. from 2014 to 2018, and Director at Epic Sciences, Inc. He also served as the President of the Global Technology Symposium at Stanford University from 2003 to 2004 and as a Partner at Asset Management Co., specifically Pitch Johnson, from 2001 to 2010.
Additionally, he was the Chief Scientific Officer at Medico-Ecological Institute from 1993 to 2000.
Dr. Zaytsev's education includes a doctorate from Altai State University in 1991 and two additional doctorates from Altai State University in 1993.
He also holds an MBA from Stanford Graduate School of Business, which he obtained in 2002.
Postes actifs de Evgeny Zaytsev
| Sociétés | Poste | Début |
|---|---|---|
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to prevent fungal and bacterial infections | Directeur/Membre du Conseil | - |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit.The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Corporate Officer/Principal | - |
Bering Capital LLC
Bering Capital LLC Investment ManagersFinance Bering Capital LLC is an active manager. | Fondateur | 01/04/2020 |
Anciens postes connus de Evgeny Zaytsev
| Sociétés | Poste | Fin |
|---|---|---|
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Président | 01/12/2018 |
| CLEARSIDE BIOMEDICAL, INC. | Directeur/Membre du Conseil | 26/09/2018 |
Asset Management Co.
Asset Management Co. Investment ManagersFinance Alternative investment manager | Corporate Officer/Principal | 30/04/2010 |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/03/2004 |
Medico-Ecological Institute
Medico-Ecological Institute Other Consumer ServicesConsumer Services Functions as a College/University | Directeur Technique/Scientifique/R&D | 01/08/2000 |
Formation de Evgeny Zaytsev
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Adastra Pharmaceuticals, Inc.
Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides clinical and commercial development of proprietary drugs | Health Technology |
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel enzyme activators to enhance the removal of toxic aldehydes | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asset Management Co.
Asset Management Co. Investment ManagersFinance Alternative investment manager | Finance |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to prevent fungal and bacterial infections | Health Technology |
Helix Ventures LLC
Helix Ventures LLC Investment ManagersFinance Helix Ventures invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early and late stage transactions. It does not invest in medical equipment, diagnostics, healthcare services or healthcare information technology companies. | Finance |
Clearside Biomedical, Inc.
Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
Altai State University
Altai State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Develops novel diagnostics to the treatment and management of cancer | Health Technology |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit.The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Finance |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medico-Ecological Institute
Medico-Ecological Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bering Capital LLC
Bering Capital LLC Investment ManagersFinance Bering Capital LLC is an active manager. | Finance |
















